June 17, 2014

Bionic pancreas successfully controls blood sugar levels



Bionic pancreas successfully controls blood sugar levels  in adults, adolescents with type 1 diabetes

The latest version of a bionic pancreas device has been successfully tested in two five-day clinical trials – one in adults, the other in adolescents – that imposed minimal restrictions on patient activities.

The latest version of a bionic pancreas device has been successfully tested in two five-day clinical trials – one in adults, the other in adolescents – that imposed minimal restrictions on patient activities.  A team of investigators from Boston University (BU) and Massachusetts General Hospital (MGH) report study results in a New England Journal of Medicine paper being issued online to coincide with a presentation at the American Diabetes Association Scientific Sessions.   The device controls blood sugar in patients with type 1 diabetes using doses of both insulin and the blood-sugar-raising hormone glucagon.